Top

Discovery offers hope for treating leukemia relapse post-transplant

September 11, 2015 by · Leave a Comment 

Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.

Read more

A new genome editing method brings the possibility of gene therapies closer to reality

July 11, 2014 by · Leave a Comment 

Researchers from Salk Institute for Biological Studies, BGI, and other institutes for the first time evaluated the safety and reliability of the existing targeted gene correction technologies, and successfully developed a new method, TALEN-HDAdV, which could significantly increased gene-correction efficiency in human induced pluripotent stem cell (hiPSC). This study published online in Cell Stell Cell provides an important theoretical foundation for stem cell-based gene therapy.

Read more

New report on stem cell research reveals the field is growing twice as fast as the world average

December 5, 2013 by · Leave a Comment 

Elsevier, EuroStemCell, and Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), today released “Stem Cell Research report: Trends and Perspectives on the Evolving International Landscape” at the World Stem Cell Summit. This new, comprehensive analysis of the growth and development of the stem cell field as a whole, closely examines the research landscape for embryonic stem (ES) cell, human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell.

Read more

Signaling molecule may help stem cells focus on making bone despite age, disease

March 9, 2013 by · Leave a Comment 

A signaling molecule that helps stem cells survive in the naturally low-oxygen environment inside the bone marrow may hold clues to helping the cells survive when the going gets worse with age and disease, researchers report.

Read more

Deadly complication of stem cell transplants reduced in mice

September 27, 2012 by · Leave a Comment 

Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns.

Read more

Bottom